|
Home : Unsafe Drugs : Avandia : Newsfeeds : GSK sales slip, but profit climbs GSK sales slip, but profit climbs
The British pharmaceutical company saw a steep drop in sales of pandemic flu vaccines and its controversial diabetes drug Avandia. Sales declines in the United States and Europe were offset by gains in emerging markets and Asia. The results met or exceeded ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




